ImmuCell Corporation, an animal health company, has released a corporate presentation highlighting its strategic opportunities and financial review. The presentation details the company's focus on expanding the sales of its First Defense® product line, aimed at improving herd productivity for dairy and beef calves by delivering immediate immunity. Additionally, it discusses the development of Re-Tain®, a purified Nisin product intended to address subclinical mastitis in dairy cows, reducing the reliance on traditional antibiotics. ImmuCell has made significant investments to enhance its production capacity for First Defense®, with an annual sales value target of over $30 million. The presentation also provides an update on the company's ongoing efforts to achieve FDA approval for its new manufacturing processes. You can access the full presentation through the link below.